×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
MASI – masimo corporation (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
MASI
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
1/12
09:00 am
masi
Masimo Announces Select Preliminary 2025 Financial Results
Medium
Report
Masimo Announces Select Preliminary 2025 Financial Results
1/7
09:00 am
masi
Masimo to Present in the J.P. Morgan 2026 Healthcare Conference
Low
Report
Masimo to Present in the J.P. Morgan 2026 Healthcare Conference
1/1
06:40 am
masi
Wells Fargo Maintains Overweight on Masimo (MASI) Following Investor Day Confidence In Long-Range Revenue Targets [Yahoo! Finance]
Low
Report
Wells Fargo Maintains Overweight on Masimo (MASI) Following Investor Day Confidence In Long-Range Revenue Targets [Yahoo! Finance]
12/5
03:20 pm
masi
HALPER SADEH LLC ENCOURAGES MASIMO CORPORATION SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS
Low
Report
HALPER SADEH LLC ENCOURAGES MASIMO CORPORATION SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS
12/5
07:21 am
masi
Masimo (NASDAQ:MASI) had its "overweight" rating reaffirmed by analysts at Wells Fargo & Company.
Low
Report
Masimo (NASDAQ:MASI) had its "overweight" rating reaffirmed by analysts at Wells Fargo & Company.
12/4
08:05 am
masi
Masimo (NASDAQ:MASI) had its price target raised by analysts at BTIG Research from $198.00 to $200.00. They now have a "buy" rating on the stock.
Medium
Report
Masimo (NASDAQ:MASI) had its price target raised by analysts at BTIG Research from $198.00 to $200.00. They now have a "buy" rating on the stock.
12/3
04:10 pm
masi
Masimo Hosts 2025 Investor Day and Details Strategic Roadmap for Durable Growth
Medium
Report
Masimo Hosts 2025 Investor Day and Details Strategic Roadmap for Durable Growth
12/1
07:03 am
masi
Masimo (NASDAQ:MASI) had its "hold" rating reaffirmed by analysts at Needham & Company LLC.
Low
Report
Masimo (NASDAQ:MASI) had its "hold" rating reaffirmed by analysts at Needham & Company LLC.
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
1/12
09:03 am
masi
Form 8-K MASIMO CORP For: Jan 12
Medium
Report
Form 8-K MASIMO CORP For: Jan 12
12/11
04:07 pm
masi
Form 144 MASIMO CORP Filed by: Tripodi Blair
Low
Report
Form 144 MASIMO CORP Filed by: Tripodi Blair
12/3
04:13 pm
masi
Form 8-K MASIMO CORP For: Dec 03
Medium
Report
Form 8-K MASIMO CORP For: Dec 03
12/1
05:23 pm
masi
Form 8-K MASIMO CORP For: Dec 01
Low
Report
Form 8-K MASIMO CORP For: Dec 01
11/28
01:44 pm
masi
Form 144 MASIMO CORP Filed by: Ahmed Omar
Neutral
Report
Form 144 MASIMO CORP Filed by: Ahmed Omar
11/17
09:41 pm
masi
Form 4 MASIMO CORP For: Nov 13 Filed by: Ahmed Omar
Low
Report
Form 4 MASIMO CORP For: Nov 13 Filed by: Ahmed Omar
11/12
08:00 pm
masi
Form SCHEDULE 13G/A MASIMO CORP Filed by: KIANI JOE E
Low
Report
Form SCHEDULE 13G/A MASIMO CORP Filed by: KIANI JOE E
11/4
05:09 pm
masi
Form 10-Q MASIMO CORP For: Sep 27
Medium
Report
Form 10-Q MASIMO CORP For: Sep 27
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/2
Masimo Announces FDA Clearance of Continuous RRp® Monitoring
9.0%
3/23 In Response to Blood Shortages Due to COVID-19, Masimo Offers Licenses for rainbow® Noninvasive Blood Constituent Monitoring, Including Total Hemoglobin, SpHb®, at No Additional Charge During the Coronavirus Pandemic 4.2%
3/12 Form 4 MASIMO CORP For: Mar 10 Filed by: KIANI JOE E 4.1%
8/6 Masimo Co. (NASDAQ: MASI) was downgraded by analysts at BidaskClub from a "strong-buy" rating to a "buy" rating. 3.8%
4/24 Form 4 MASIMO CORP For: Apr 22 Filed by: KIANI JOE E 3.0%
6/7 Form 4 MASIMO CORP For: Jun 05 Filed by: Muhsin Bilal 3.0%
8/14 Form 4 MASIMO CORP For: Aug 12 Filed by: Lee Yongsam 3.0%
5/16 Masimo Announces FDA Clearance of Radius PPG™, the First Tetherless SET® Pulse Oximetry Sensor Solution 3.0%
6/3 Form 4 MASIMO CORP For: May 30 Filed by: Cohen H Michael 2.6%
1/17 Form 4 MASIMO CORP For: Jan 16 Filed by: Young Micah W 2.3%
3/23 In Response to Blood Shortages Due to COVID-19, Masimo Offers Licenses for rainbow® Noninvasive Blood Constituent Monitoring, Including Total Hemoglobin, SpHb®, at No Additional Charge During the Coronavirus Pandemic 4.2%
3/12 Form 4 MASIMO CORP For: Mar 10 Filed by: KIANI JOE E 4.1%
8/6 Masimo Co. (NASDAQ: MASI) was downgraded by analysts at BidaskClub from a "strong-buy" rating to a "buy" rating. 3.8%
4/24 Form 4 MASIMO CORP For: Apr 22 Filed by: KIANI JOE E 3.0%
6/7 Form 4 MASIMO CORP For: Jun 05 Filed by: Muhsin Bilal 3.0%
8/14 Form 4 MASIMO CORP For: Aug 12 Filed by: Lee Yongsam 3.0%
5/16 Masimo Announces FDA Clearance of Radius PPG™, the First Tetherless SET® Pulse Oximetry Sensor Solution 3.0%
6/3 Form 4 MASIMO CORP For: May 30 Filed by: Cohen H Michael 2.6%
1/17 Form 4 MASIMO CORP For: Jan 16 Filed by: Young Micah W 2.3%
TOP News Decliners
5/6
Q1/2019 3/30/2019 EPS 0.790 ZacksConsensus 0.750 ActVsEst 0.040 - Beat
-6.9%
3/19 Masimo Announces Agreement to Acquire TNI medical AG -5.5%
4/28 Masimo Corp (MASI) CEO Joe Kiani on Q1 2020 Results - Earnings Call Transcript [Seeking Alpha] -5.4%
9/9 Masimo Announces Development of Delta cHb, HHb, and O2Hb Indices for O3® -5.3%
10/30 Form 10-Q MASIMO CORP For: Sep 28 -4.2%
3/23 In Response to Blood Shortages Due to COVID-19, Masimo Offers Licenses for rainbow® Noninvasive Blood Constituent Monitoring, Including Total Hemoglobin, SpHb®, at No Additional Charge During the Coronavirus Pandemic -4.1%
4/16 Masimo and Samsung Partner to Package Masimo SafetyNet™ with Select Samsung Phones to Speed COVID-19 Response Efforts -3.7%
8/2 Form 4 MASIMO CORP For: Jul 31 Filed by: KIANI JOE E -3.3%
7/31 Form 8-K MASIMO CORP For: Jul 31 -3.2%
2/20 Masimo Co. (NASDAQ: MASI) had its price target raised by analysts at UBS Group AG from $190.00 to $207.00. They now have a "buy" rating on the stock. -2.8%
3/19 Masimo Announces Agreement to Acquire TNI medical AG -5.5%
4/28 Masimo Corp (MASI) CEO Joe Kiani on Q1 2020 Results - Earnings Call Transcript [Seeking Alpha] -5.4%
9/9 Masimo Announces Development of Delta cHb, HHb, and O2Hb Indices for O3® -5.3%
10/30 Form 10-Q MASIMO CORP For: Sep 28 -4.2%
3/23 In Response to Blood Shortages Due to COVID-19, Masimo Offers Licenses for rainbow® Noninvasive Blood Constituent Monitoring, Including Total Hemoglobin, SpHb®, at No Additional Charge During the Coronavirus Pandemic -4.1%
4/16 Masimo and Samsung Partner to Package Masimo SafetyNet™ with Select Samsung Phones to Speed COVID-19 Response Efforts -3.7%
8/2 Form 4 MASIMO CORP For: Jul 31 Filed by: KIANI JOE E -3.3%
7/31 Form 8-K MASIMO CORP For: Jul 31 -3.2%
2/20 Masimo Co. (NASDAQ: MASI) had its price target raised by analysts at UBS Group AG from $190.00 to $207.00. They now have a "buy" rating on the stock. -2.8%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: